Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune-modifying therapies

JCI Insight(2023)10.1172/jci.insight.168663Source: DataRank Database

Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune-modifying therapies is a research paper published in JCI Insight (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.49)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Lauren B. Rodda ORCID,Chihiro Morishima ORCID,Mark H. Wener ORCID,Yevgeniy Yuzefpolskiy ORCID,Estelle Bettelli ORCID

Live enrichment

PubMed:37338983 PMC:PMC10445680 OpenAlex:https://openalex.org/W4381431597

NIH Office of the Director

Grant: R01AI127726

National Institutes of Health

Grant: 5R01AI127726-05

Regulation of cutaneous immunity and tissue-repair by a specialized population of CD4+ T cells

FWCI

2.49

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1172/jci.insight.168663

publisherhttps://doi.org/10.1172/jci.insight.168663

publisherhttps://insight.jci.org/articles/view/168663/files/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37338983

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10445680

Fields of Study

SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesPeripheral Neuropathies and Disorders03 medical and health sciences0302 clinical medicineHumansCOVID-19 VaccinesCOVID-19SARS-CoV-2Arthritis, RheumatoidAntibodies, ViralRNA, Messenger

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAntibodies, ViralArthritis, RheumatoidHumansRNA, Messenger

Keywords

Rheumatoid arthritisCoronavirus disease 2019 (COVID-19)Immune systemMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Immunology2019-20 coronavirus outbreakMessenger RNAInternal medicineBioinformaticsVirologyBiologyDiseaseGeneInfectious disease (medical specialty)GeneticsVaccinesAutoimmunitycostimulationadaptive immunityCOVID-19 VaccinesSARS-CoV-2RCOVID-19Antibodies, ViralArthritis, RheumatoidHumansRNA, MessengerResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being